These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 20652950)

  • 41. Critical role of PDE4D in beta2-adrenoceptor-dependent cAMP signaling in mouse embryonic fibroblasts.
    Bruss MD; Richter W; Horner K; Jin SL; Conti M
    J Biol Chem; 2008 Aug; 283(33):22430-42. PubMed ID: 18508768
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cyclic nucleotide phosphodiesterase isoforms in human basophils and mast cells.
    Eskandari N; Tashrifi F; Bastan R; Andalib A; Yousefi Z; Peachell PT
    Int J Immunopathol Pharmacol; 2016 Dec; 29(4):654-665. PubMed ID: 26781461
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of inactivated Bordetella pertussis on phosphodiesterase in the lung of ovalbumin sensitized and challenged rats.
    Wang YJ; Song SD; Chen JC; Wang XF; Jiang YL; Xie QM; Chen JQ; Li ZG; Tang HF
    Pulm Med; 2014; 2014():581738. PubMed ID: 25120928
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The upstream conserved regions (UCRs) mediate homo- and hetero-oligomerization of type 4 cyclic nucleotide phosphodiesterases (PDE4s).
    Xie M; Blackman B; Scheitrum C; Mika D; Blanchard E; Lei T; Conti M; Richter W
    Biochem J; 2014 May; 459(3):539-50. PubMed ID: 24555506
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phosphodiesterase 4B knockout prevents skeletal muscle atrophy in rats with burn injury.
    Balasubramaniam A; Sheriff S; Friend LA; James JH
    Am J Physiol Regul Integr Comp Physiol; 2018 Aug; 315(2):R429-R433. PubMed ID: 29693432
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An evolutionary analysis of cAMP-specific Phosphodiesterase 4 alternative splicing.
    Johnson KR; Nicodemus-Johnson J; Danziger RS
    BMC Evol Biol; 2010 Aug; 10():247. PubMed ID: 20701803
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PDE4D and PDE4B function in distinct subcellular compartments in mouse embryonic fibroblasts.
    Blackman BE; Horner K; Heidmann J; Wang D; Richter W; Rich TC; Conti M
    J Biol Chem; 2011 Apr; 286(14):12590-601. PubMed ID: 21288894
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sex-related differences of cAMP-specific PDE4B3 mRNA in oligodendrocytes following systemic inflammation.
    Johansson EM; Sanabra C; Mengod G
    Glia; 2012 Dec; 60(12):1815-25. PubMed ID: 22848007
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti‑inflammatory effect of ciclamilast in an allergic model involving the expression of PDE4B.
    Zheng XY; Chen JC; Xie QM; Chen JQ; Tang HF
    Mol Med Rep; 2019 Mar; 19(3):1728-1738. PubMed ID: 30628641
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phosphodiesterase isoform-specific expression induced by traumatic brain injury.
    Oliva AA; Kang Y; Furones C; Alonso OF; Bruno O; Dietrich WD; Atkins CM
    J Neurochem; 2012 Dec; 123(6):1019-29. PubMed ID: 23057870
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PDE4 subtypes in cancer.
    Hsien Lai S; Zervoudakis G; Chou J; Gurney ME; Quesnelle KM
    Oncogene; 2020 May; 39(19):3791-3802. PubMed ID: 32203163
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phosphodiesterase-4 (PDE4) molecular pharmacology and Alzheimer's disease.
    Gurney ME; D'Amato EC; Burgin AB
    Neurotherapeutics; 2015 Jan; 12(1):49-56. PubMed ID: 25371167
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of the Pharmacological Profiles of Selective PDE4B and PDE4D Inhibitors in the Central Nervous System.
    Zhang C; Xu Y; Zhang HT; Gurney ME; O'Donnell JM
    Sci Rep; 2017 Jan; 7():40115. PubMed ID: 28054669
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phosphodiesterase 4D: an enzyme to remember.
    Ricciarelli R; Fedele E
    Br J Pharmacol; 2015 Oct; 172(20):4785-9. PubMed ID: 26211680
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of Phosphodiesterase 4B cAMP-Specific Gene in Subjects With Cryptorchidism and Down's Syndrome.
    Salemi M; Condorelli RA; La Vignera S; Castiglione R; Salluzzo MG; Bonaccorso CM; Vinci M; Bosco P; Romano C; Campagna C; Romano C; Calogero AE
    J Clin Lab Anal; 2016 May; 30(3):196-9. PubMed ID: 25546171
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of PDE4 pathway inhibition in rat experimental stroke.
    Yang F; Sumbria RK; Xue D; Yu C; He D; Liu S; Paganini-Hill A; Fisher M
    J Pharm Pharm Sci; 2014; 17(3):362-70. PubMed ID: 25224348
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Discovery of sulfonyl hydrazone derivative as a new selective PDE4A and PDE4D inhibitor by lead-optimization approach on the prototype LASSBio-448: In vitro and in vivo preclinical studies.
    Nunes IKDC; de Souza ET; Martins IRR; Barbosa G; Moraes Junior MO; Medeiros MM; Silva SWD; Balliano TL; da Silva BA; Silva PMR; Carvalho VF; Martins MA; Lima LM
    Eur J Med Chem; 2020 Oct; 204():112492. PubMed ID: 32717478
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A novel de novo PDE4D gene mutation identified in a Chinese patient with acrodysostosis.
    Zhan Y; Chen W; Feng Z; Tan C; Li M; Song Y; Zhao Z; Sheng W; Huang G
    Genesis; 2019 Nov; 57(11-12):e23336. PubMed ID: 31520578
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Location, location, location: PDE4D5 function is directed by its unique N-terminal region.
    Wills L; Ehsan M; Whiteley EL; Baillie GS
    Cell Signal; 2016 Jul; 28(7):701-5. PubMed ID: 26808969
    [No Abstract]   [Full Text] [Related]  

  • 60. Editorial.
    Baillie GS
    Cell Signal; 2016 Jul; 28(7):699-700. PubMed ID: 26850139
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.